Status:
COMPLETED
Individualized Analgesia for Pediatric Adenotonsillectomy
Lead Sponsor:
Children's Hospital of Fudan University
Conditions:
Adenotonsillectomy
Analgesia
Eligibility:
All Genders
3-10 years
Phase:
PHASE4
Brief Summary
The objective of this randomized clinical trial is to assess the safety and effectiveness of post-adenotonsillectomy analgesia with individualized opioid analgesia regime in children.
Detailed Description
Patients will be randomly assigned to individualized opioid analgesia regimen group or conventional opioid analgesia regimen group. Intravenous 1μg/kg fentanyl is administered as a test in patients w...
Eligibility Criteria
Inclusion
- Children, ASA physical status I or II, who is scheduled to undergo adenotonsillectomy will be recruited.
Exclusion
- Children with craniofacial deformities, neuromuscular diseases, mental retardation, body mass index \> 30kg/m2 , or a recent history of opioid use are excluded.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2024
Estimated Enrollment :
542 Patients enrolled
Trial Details
Trial ID
NCT04527393
Start Date
May 1 2022
End Date
January 10 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's hospital of Fudan university
Shanghai, China